Pharmaceuticals

slld84.JPG

Single-use Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product (Single-use Bioreactors, Single-use Mixers, Single-use Media Bags, Single-use Filters, Single-use Sampling Systems, Single-use Connectors, Others), By Scale, By End Users, Region And Segment Forecasts, 2023-2031.

The Single-use Upstream Bioprocessing Market is expected to grow at a 15.7 % CAGR during the forecast period for 2023-2031. The first step in the bioprocess is upstream bioprocessing, which is used to generate cell lines and cultivate them in orde...

View Sample PDF

slld95.JPG

Smart ICU Beds & Heads Market Size, Share & Trends Analysis Report By Product Type (Smart Bed Heads, Mechatronic ICU Beds), By Patient Type (Pediatric & Neonatal, Bariatric, Geriatric, Psychiatric, and Others), By Type, Region And Segment Forecasts, 2023-2031.

The Smart ICU Beds & Heads Market is expected to grow at a 5.5 % CAGR during the forecast period for 2023-2031. Smart beds are networked to give a variety of medical data, including personal data such as weight, body temperature, pulse, blood ...

View Sample PDF

slld96.JPG

Proteome Profiling Services Market Size, Share & Trends Analysis Report By Application (Drug Discovery, Disease Diagnosis, Others), By Sponsors (Pharmaceutical Companies, Research and Academics Institutes, CROs), By Region, And By Segment Forecasts, 2023-2031.

The Proteome Profiling Services Market is expected to grow at an 11.5 % CAGR during the forecast period for 2023-2031. Proteome profiling refers to the high-throughput analysis of biological samples at a large scale for identifying, detecting, and...

View Sample PDF

Infection_Surveillance_Solutions_Market.JPG

Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Product & Services (Software (On-premise Software, Web-based Software), Up to 50 hp (Product Support & Maintenance Services, Implementation Services, Training & Consulting services), By End User, By Region, And By Segment Forecasts, 2023-2031

The Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031. The term "infection surveillance solutions" re...

View Sample PDF

The_Animal_Placental_Protein_Market.JPG

Animal Placental Protein Market Size, Share & Trends Analysis Report By Product Type (Animal Placental Protein Extracts, Animal Placental Protein Powders, Animal Placental Protein Capsules/Tablets, Animal Placental Protein Injections), By Application, By Animal Source, By End-user, By Distribution Channel, By Region, And By Segment Forecasts, 2023-2031.

The Animal Placental Protein Market Size is valued at USD 527.09 Mn in 2022 and is predicted to reach USD 837.97 Mn by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031. Animal placental proteins refer to proteins that are obta...

View Sample PDF

sllld1.JPG

Enzyme Immunoassay (EIA) Reagents and Kits Market Size, Share & Trends Analysis Report By Product Type (reagents and kits), Technology (competitive ELISA, indirect ELISA, sandwich ELISA, and multiple/portable ELISA), Applications, Region And Segment Forecasts, 2023-2031.

The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031. Enzyme Immunoassay (EIA) test is one ...

View Sample PDF

Infographics_Global_Fragile_X_Syndrome_Market_1.jpg

Fragile X Syndrome Market Size, Share & Trends Analysis Report By Treatment (Ssris, Psychostimulants, Atypical Antipsychotics, Anticonvulsants, Antihypertensive Anxiolytics, Benzodiazepines, Lithium, Other Antidepressants), Region And Segment Forecasts, 2023-2031.

The Fragile X Syndrome Market Size is valued at 20.80 Million in 2022 and is predicted to reach 37.71 Million by the year 2031 at a 7.0 % CAGR during the forecast period for 2023-2031.  Fragile X syndrome is a hereditary condition that causes a...

View Sample PDF

Slideiju.JPG

Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size, Share & Trends Analysis Report By Drug Types (Lepirudin, Danaparoid, Argatroban), By Test Types (Enzyme Immunoassay (EIA), Serotonin Release Assay (SRA), Enzyme-Linked Immunosorbent Assay (ELISA), Heparin-Induced Platelet Activation (HIPA) Test), By End User, By Region, And By Segment Forecasts, 2024-2031

The Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size is valued at USD 9.38 billion in 2023 and is predicted to reach USD 13.55 billion by the year 2031 at a 4.81% CAGR during the forecast period for 2024-2031. Heparin-induced thrombocy...

View Sample PDF

slld34.JPG

Gene Therapies For Rare Diseases Market Size, Share & Trends Analysis Report By Product (Zolgensma, Invossa K, Strimvelis, Neovasculgen, Glybera, Luxturna, Zynteglo, and Others), By Disease Type, Region And Segment Forecasts, 2023-2031.

The Gene Therapies For Rare Diseases Market is expected to grow at an 20.0 % CAGR during the forecast period for 2023-2031. Gene Therapy is playing a major role in rare disease management. Gene therapy in rare diseases is a specialized and targete...

View Sample PDF

slld60.JPG

Gene Therapy For Retinal Diseases Market Size, Share & Trends Analysis Report By Indication (Choroideremia (CHM), Leber Congenital Amaurosis, Leber’s Hereditary Optic Neuropathy, X-Linked Retinitis Pigmentosa, and Other Indications), Region And Segment Forecasts, 2023-2031.

The Gene Therapy For Retinal Diseases Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031. Gene therapy states a method of announcing foreign DNA constructs into host cells in demand to treat various medical condit...

View Sample PDF

Categories